Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of APP13007 for the Treatment of Inflammation and Pain After Cataract Surgery

NCT04739709 is registered in ClinicalTrials.gov with Formosa Pharmaceuticals, Inc. as lead sponsor.

NCT NCT04739709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04739709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of APP13007 for the Treatment of Inflammation and Pain After Cataract Surgery
Lead sponsor
Formosa Pharmaceuticals, Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 11, 2021
Completion date
March 17, 2022
Enrollment
378 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

ocular inflammation and pain